MedTrace Logo

Preoperative High Protein vs Immunodiet in Surgical Cancer Patients

NCT03980704 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 299

Last updated 2021-07-26

No results posted yet for this study

Summary

Immunomodulating nutrition is supposed to reduce the number of complications and the legnth of the hospital stay during the postoperative period in patients after major gastrointestinal surgery. The aim of the study is to assess the clinical effect of immunomodulating oral nutrition in patients undergoing resection for gastrointestinal cancer in the group of well-nourished patients.

Conditions

  • General Surgery
  • Cancer of Colon

Interventions

DRUG

IMPACT

Administration of oral immunostimulating oral supplement

DRUG

resource protein

Administration of oral high-protein oral supplement

Sponsors & Collaborators

  • Stanley Dudrick's Memorial Hospital

    lead OTHER

Principal Investigators

  • Stanislaw Klek · Stanley Dudrick's Memorial Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2020-12-31
Completion
2021-03-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03980704 on ClinicalTrials.gov